Magenta Lifecare Reports No Deviations in IPO Fund Utilization for Half Year Ended September 2025
Magenta Lifecare Limited has confirmed no deviations in IPO fund utilization for the half year ended September 30, 2025, in a compliance filing with BSE. The company allocated ₹424.00 lakhs for incremental working capital requirements and ₹174.00 lakhs for general corporate purposes, exactly as originally planned, demonstrating complete adherence to stated fund utilization objectives.

*this image is generated using AI for illustrative purposes only.
Magenta Lifecare Limited has filed a compliance statement with BSE Limited confirming no deviations in the utilization of its Initial Public Offering (IPO) proceeds for the half year ended September 30, 2025. The statement, submitted on December 20, 2025, demonstrates the company's adherence to regulatory requirements under SEBI Listing Regulations.
Regulatory Compliance Statement
The filing was made pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019. Managing Director Divyesh Modi (DIN: 02016172) signed the compliance document, affirming that no variations occurred in the planned fund utilization during the reporting period.
IPO Fund Allocation Details
The company's IPO proceeds were allocated across two primary objectives, with actual utilization matching the original allocation exactly:
| Original Object | Modified Object | Original Allocation (₹ Lakhs) | Modified Allocation (₹ Lakhs) | Funds Utilized | Deviation/Variation |
|---|---|---|---|---|---|
| Incremental Working Capital Requirements | No | 424.00 | 424.00 | Nil | Nil |
| General Corporate Purpose | No | 174.00 | 174.00 | Nil | Nil |
The total IPO proceeds of ₹598.00 lakhs were distributed with the majority portion (₹424.00 lakhs) allocated for meeting incremental working capital requirements, while ₹174.00 lakhs was designated for general corporate purposes.
Fund Utilization Transparency
The statement confirms that there were no changes in the objects or purposes for which the funds were raised, no deviations in the amount of funds actually utilized against what was originally disclosed, and no changes in terms of contracts referred to in the fund-raising documents. The Audit Committee reviewed the fund utilization and provided no adverse comments.
Company Background
Magenta Lifecare Limited, formerly known as Magenta Lifecare Private Limited, operates in the mattresses and pillows segment. The company is headquartered at N.P. Patel Estate, Padamla, District Vadodara-391350, Gujarat, and trades on BSE with security code 544188 under the symbol MAGENTA.
This compliance filing reinforces the company's commitment to transparent fund management and regulatory adherence, providing stakeholders with confidence in the proper utilization of IPO proceeds according to the stated objectives.
Historical Stock Returns for Magenta Lifecare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |





























